IL10 and colitis: As corollary, the carcinogenic properties, demonstrated in vitro and in vivo, are collateral damage exerted under specific circumstances such as genetic susceptibility to cancer (haploinsufficiency of tumor suppressor genes, e.g., APC), inflammatory conditions (DSS-induced colitis or IL10 deficiency), and establishment of a chronic carrier status rather than an acute infection.